References

1. Fraidenburg DR, Machado RF. Pulmonary hypertension associated with thalassemia syndromes. Ann NY Acad Sci 2016; 1368:127–139
2. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99:36–43
3. Mahesh B, Besser M, Ravaglioli A, et al . Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience. Eur J Cardio-Thorac Surg 2016; 50:537–541
4. Roggero S, Vullo S, Volpe G, Piga A, Albera C. Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report. J Thromb Thrombolysis 2015; 39:139-43
5. Jamieson SW, Auger WR, Fedullo PF, et al . Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993; 106:116–127
6. Simonneau G, Robbins IM, Beghetti M, et al . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54(1 Suppl):S43-54
7. Scholzel BE, Post MC, Plokker HT, Snijder RJ. Clinical worsening during long-term follow-up in inoperable chronic thromboembolic pulmonary hypertension. Lung 2011; 190:161–167
8. Karyofyllis P, Tsiapras D, Papadopoulou V, et al . Balloon pulmonary angioplasty is a promising option in thalassemic patients with inoperable chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis 2018, 46:516-520